Parabilis Medicines, Inc.
PBLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657677
In the last 90 days, Parabilis Medicines, Inc. insiders filed 1 open-market purchase and 0 sales; 79 institutions reported holding it in 13F filings for Q2 2026, worth $2.71B in total; no superinvestor holds it.
Holders of 5% or more of PBLS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Parabilis Medicines, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 13D | 23.80%28.9M shares | New | Jun 18, 20261 filing | Jun 18, 2026 | SEC |
| FMR LLC | 13G | 8.50%10.3M shares | New | Aug 6, 20261 filing | Aug 6, 2026 | SEC |
| ARCH Venture Fund XII, L.P. | 13G | 5.30%6.41M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Parabilis Medicines, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:05 PM ET | ARCH Venture Fund XII, L.P.and 6 others | 13G | 5.30%6.41M shares | New | Jun 30, 2026 | SEC |
| Aug 6, 202610:38 AM ET | FMR LLCand 1 other | 13G | 8.50%10.3M shares | New | Jun 30, 2026 | SEC |
| Jun 18, 20264:09 PM ET | Ra Capital Management, L.P.and 3 others | 13D | 23.80%28.9M shares | New | Jun 11, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Parabilis Medicines, Inc. shares.
No Form 144 notices for Parabilis Medicines, Inc. are on file.